Chinese Sle Treatment And Research Group

This study tests a new drug called Firsekibart in 15 adults with mild to moderate lupus that hasn't improved with usual treatments. The drug blocks a protein involved in inflammation, aiming to reduce lupus symptoms like fever and organ inflammation. Researchers will check if pat…

This study tests two experimental drugs, vunakizumab and ivarmacitinib, in 180 adults with active Takayasu's arteritis, a rare disease that inflames arteries. The goal is to see if these drugs can control the disease better than standard steroid treatments. Participants will take…